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ABSTRACT 
Objectives: Data on the role of tobacco exposure in systemic sclerosis ゅSScょ severity and progression are scarce┻ We aimed to assess the effects of smoking on the evolution of pulmonary and skin manifestations in the EUSTAR database┻ 
Methods: Adult SSc patients with data on smoking history and a なに┽にね months follow┽up visit were included┻ Associations of severity and progression of organ involvement with smoking history and the comprehensive smoking index ゅCS)ょ were assessed using multivariable regression analyses┻  
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The baseline modified Rodnan skin score ゅmRSSょ and the mRSS decline were comparable across smoking groups┻  Although heavy smoking ゅmore than にの pack yearsょ increased the odds of digital ulcers by almost のどガ┸ there was no robust adverse association of smoking with digital ulcer development┻ 
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Statistical analysis Frequencies【percentages or means【standard deviations ゅSDょ were calculated┹ groups were compared using やに┽tests【Fisher╆s exact tests or t┽tests【ANOVA┻ Multiple linear and logistic regression analyses were applied to adjust outcome【exposure associations with 
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variable per unit CS) increase┻ OR values larger than one indicate that increased smoking increases the likelihood of occurrence of the outcome┻ Missing data were imputed using multiple imputation with chained equations いひう┻ The regression analyses shown in this paper are all based on imputed data┹ the results based on a complete case analysis are represented in Supplementary Table は┻ Analyses were performed with Stata【)Cなの┻な ゅStataCorp┸ USAょ┻ 
 
RESULTS  
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previous smoker group possibly leading to worse trajectories in lung function measures┻ Therefore┸ in addition to analyzing the entire study population┸ we also analyzed the progression of lung function measures separately for patients with )LD on high resolution CT ゅ(RCTょ and patients without )LD on (RCT┻ Among all patients┸ ねひガ had signs of )LD on (RCT┻ The smoking behavior patterns were similar in patients with )LD and in patients without )LD┹ はぱガ of patients in both groups were never smokers┸ にぬガ of patients with and にどガ of patients without )LD were previous smokers┸ and ひガ of patients with and なにガ of patients without )LD were current smokers ゅpサど┻どはょ┻  
FEV1/FVC ratio Never smokers had a significantly higher baseline FEVな【FVC ratio than previous and current smokers ゅTable なょ┻ These differences in baseline FEVな【FVC ratio were seen in all three smoking models ゅFigure な┹ Table に┹ Supplementary Table ばょ┻ As can be seen in Table に┸ patients had a に┻ば unit lower FEVな【FVC ratio per unit increase in the CS)┻ Medium and heavy smokers had lower baseline FEVな【FVC ratios than never smokers and light smokers ゅall pジど┻どどな┹ Supplementary Table ばょ┻ )n univariable analysis┸ the FEVな【FVC ratio declined similarly across smoking groups ゅpサど┻どはのょ┹ in multivariable analysis┸ the FEVな【FVC ratio however declined faster in current smokers ゅFigure なょ┹ this result was also observed when stratifying the study population into )LD and non┽)LD patients ゅdata not shownょ┻ 
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な┹ Table に┹ Supplementary Table ばょ┻ This lack was also observed when assessing the FVC changes separately for )LD and non┽)LD patients ゅdata not shownょ┻  
 
DLCO/sb Smokers had lower baseline DLCO【sb levels than never smokers ゅpジど┻どどな┹ Table なょ┹ smoking was associated with low baseline DLCO【sb in all three models ゅFigure な┹ Table に┹ Supplementary Table ばょ┻ The DLCO【sb declined similarly across all three smoking behavior groups in univariable ゅTable なょ and multivariable analysis ゅFigure な┹ Table に┹ Supplementary Table ばょ┸ these results were also true when looking at )LD and non┽)LD patients separately ゅdata not shownょ┻ 
 
PAPsys The average baseline PAPsys was slightly higher in never smokers than in current or ex┽smokers ゅTable なょ┻ These differences stayed apparent but to a lesser extent not only when assessing the smoking groups multivariably┸ but also evaluating smoking intensity and the CS) ゅFigure な┹ Table に┹ Supplementary Table ばょ┻ The PAPsys increased similarly in the groups in univariable ゅTable なょ and multivariable analysis ゅFigure な┹ Table に┹ Supplementary Table ばょ┻ 
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)n all smoking models┸ no clinically significant difference in mRSS evolution was observed ゅTable な┹ Figure な┹ Table に┹ Supplementary Table ばょ┻ 
 
DU The prevalence of DUs was comparable in the smoking behavior groups ゅTable なょ┻ (owever┸ heavy smokers had a greater likelihood of DUs than never smokers in multivariable analysis ゅORサな┻は┸ pサど┻どに┹ Supplementary Table ばょ┹ also┸ a higher CS) was associated with the presence of DUs at baseline ゅORサな┻に┸ pサど┻どどに┸ i┻e┻ for a one unit increase in CS)┸ the odds of having DUs at baseline increases by a factor of な┻なひ┹ Table にょ┻ )n the sub┽group of DU┽naïve patients at baseline┸ なねガ of never smokers developed new DUs in between the two visits┸ compared to なはガ ex┽smokers and ぱガ current smokers ゅpサど┻どのょ┻ Ex┽smokers had comparable odds than never smokers to develop DU between the two visits ゅORサな┻な┸ pサど┻ばょ┹ current smokers developed DUs less often than never smoking patients ゅORサど┻の┸ pサど┻どぬなょ┻ The smoking intensity was not associated with incident DU during the observation period ゅSupplementary Table ばょ┻ 
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Like all registry┽based studies the EUSTAR cohort has limitations┻ We had no means to verify the smoking information provided by the patients┸ however we were able to demonstrate known adverse effects of smoking on airway obstruction suggesting that the information provided by the patients was not random and that our study was powered to detect meaningful changes in other parameters┻  By requiring the study population to have a follow┽up visit there is a possibility that we excluded sicker patients┸ i┻e┻ that we introduced a selection bias for healthier patients┻ (owever┸ at baseline the patients that were excluded due to the absence of a follow┽up visit within the required time frame were not majorly worse off than the included patients ゅSupplementary Table のょ arguing against a major selection bias┻ )n summary┸ our study demonstrates an adverse effect of smoking on pulmonary airways┸ but no effects on SSc┽specific pulmonary and cutaneous involvement┻ These data argue against a major role of tobacco associated free radicals┸ vasoconstrictory and immunomodulatory effects in the pathogenesis of SSc vasculopathy and fibrosis┻ 
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Table 1. Baseline demographic and disease characteristics as well as outcome measures by smoking status┻  ACA┸ anticentromere autoantibodies┹ DLCO【sb┸ single breath diffusing capacity for monoxide┹ ESR┸ erythrocyte sedimentation rate┹ FEVな┸ forced expiratory volume in one second┹ FVC┸ forced vital capacity┹ LVEF┸ left ventricular ejection fraction┹ mRSS┸ modified Rodnan skin score┹ NY(A┸ New York heart association┹ PAPsys┸ systolic  pulmonary artery pressure as estimated by echocardiography┹ RNAP┽)))┸ anti┽RNA polymerase┽))) autoantibodies┹ RP┸ Raynaud╆s phenomenon┹ Scl┽ばど┸ anti┽topoisomerase autoantibodies┻  こbased on the follow┽up visit┸ not the なに months projection┻ ここThe changes in outcomes are given downscaled to ╉per なに month╊┻ おNumber of patients with available information for each variable┻ 









ガ or  mean ゅSDょ ガ or  mean ゅSDょ ガ or  mean ゅSDょ N   ににどの ばのに ぬはに  Age┹ years ぬぬなひ のば┻の ゅなね┻なょ のば┻に ゅなに┻なょ のに┻の ゅなな┻にょ ジど┻どどな Male sex ぬぬなひ ぱ にば にひ ジど┻どどな 
Disease characteristics        Time since RP onset┹ years  ぬにぱは なね┻ひ ゅなな┻ばょ なぬ┻ね ゅなな┻ぬょ なぬ┻ぬ ゅなな┻ぱょ ど┻どどな Time since first non┽RP manifestation┹ years にひぱぱ なな┻ば ゅぱ┻ぱょ など┻の ゅぱ┻ばょ ぱ┻ひ ゅば┻ぱょ ジど┻どどな 
Skin involvement 
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mRSS にひねひ ば┻ば ゅば┻ねょ ば┻ぱ ゅば┻ひょ は┻ひ ゅば┻ぬょ ど┻なね Follow┽up mRSSこ にぱぬひ ば┻ね ゅば┻にょ ば┻に ゅば┻なょ は┻ひ ゅは┻ひょ ど┻ねど Change in mRSSここ にはぱね ┽ど┻ぬ ゅぬ┻ねょ ┽ど┻は ゅね┻どょ ┽ど┻に ゅぬ┻ぬょ ど┻なに Esophageal symptoms ぬにばの はど はは のぱ ど┻どなど Stomach symptoms ぬにねな にぬ にぬ にな ど┻はぱ )ntestinal symptoms ぬにのど にば ぬど にひ ど┻にね 
Dyspnea┹ NY(A functional class 
) ぬななね のば のね はぬ 
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Follow┽up PAPsysこ┹ mm(g にどのの にひ┻に ゅなぬ┻はょ にぱ┻の ゅなね┻なょ にね┻ば ゅなな┻はょ ジど┻どどな Change in PAPsysここ┹ mm(g なばどは ど┻は ゅなど┻のょ な┻は ゅぱ┻のょ ど┻に ゅぱ┻なょ ど┻なぱ 
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Table 2. Regression analysis comparing outcomes at baseline and progression of outcomes according to the comprehensive smoking index ゅCS)ょ adjusted for age┸ sex┸ time since the onset of Raynaud╆s phenomenon┸ time since the first non┽Raynaud╆s phenomenon manifestation┸ antibody status and extent of skin involvement┻ The first column illustrates the mean and the range of each outcome╆s CS) based on the imputed dataset┻ (igher CS)s indicate more smoking┹ never smokers carry a CS) of ど┻  The beta values represent the additive increase or decrease in the outcome variable per unit increase in the CS)┻ The OR values represent the increase in odds for the presence of the outcome variable per unit CS) increase┻ OR values larger than one indicate that increased smoking increased the likelihood of occurrence of the outcome┻  The follow┽up part of the table assesses the projected change per なに months of the outcomes┻ C)┸ confidence interval┹ DLCO【sb┸ single breath diffusing capacity for monoxide┹ DU┸ digital ulcers┹ FEVな┸ forced expiratory volume in one second┹ FVC┸ forced vital capacity┹ mRSS┸ modified Rodnan skin score┹ OR┸ odds ratios┹ PAPsys┸ systolic pulmonary artery pressure as estimated by echocardiography┻ 
Outcomes  Mean CSI 
(range) 
CSI が or OR ひのガC) p┽value 
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DU current  ど┻ぬの ゅど┽ば┻ひねょ ORサ な┻なひ な┻どば to な┻ぬに ど┻どどに 
Follow-up     FEVな【FVC ど┻ぬぬ ゅど┽は┻はひょ がサ ┽ど┻ねの ┽ど┻ひぬ to ど┻どに ど┻どのひ FVC ど┻ねは ゅど┽は┻ぬはょ がサ ど┻ぬに ┽ど┻どな to ど┻はは ど┻どのひ DLCO【SB ど┻ねぬ ゅど┽ね┻どにょ がサ ど┻ぬば ┽ど┻なは to ど┻ひど ど┻なば PAPsys ど┻ぬの ゅど┽は┻なひょ がサ ┽ど┻にな ┽ど┻ばは to ど┻ぬね ど┻ねの mRSS ど┻ねぬ ゅど┽は┻ぬはょ がサ ┽ど┻なは ┽ど┻にひ to ┽ど┻どに ど┻どにな DU new btw visits  ど┻ぬど ゅど┽ぱ┻ぬばょ ORサ ど┻ぱぬ ど┻はぱ to な┻どど ど┻どのは 
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